AGP Picks
View all

Health Review Macao
Provided by AGP

Health Review Macao: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Review Macao.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 19, 2026

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
May 19, 2026

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

Indeterminate GlobeNewswire
リゼン・ファーマ、アルツハイマー病による軽度認知障害を対象としたRP902の、第2相治験の開始を発表
May 19, 2026

リゼン・ファーマ、アルツハイマー病による軽度認知障害を対象としたRP902の、第2相治験の開始を発表

Indeterminate GlobeNewswire
Risen Pharma, 알츠하이머병 관련 경도인지장애 치료제 RP902 임상 2상 개시 발표
May 19, 2026

Risen Pharma, 알츠하이머병 관련 경도인지장애 치료제 RP902 임상 2상 개시 발표

Indeterminate GlobeNewswire
Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy
May 19, 2026

Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy

Indeterminate GlobeNewswire
NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment
May 19, 2026

NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment

Indeterminate GlobeNewswire
AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities
May 19, 2026

AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities

Indeterminate GlobeNewswire
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026
May 19, 2026

Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026

Indeterminate GlobeNewswire
Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium
May 19, 2026

Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium

Indeterminate GlobeNewswire
ITM to Announce Dosimetry Data from the Phase 3 COMPETE Trial at SNMMI 2026 and Host Satellite Symposium
May 19, 2026

ITM to Announce Dosimetry Data from the Phase 3 COMPETE Trial at SNMMI 2026 and Host Satellite Symposium

Indeterminate GlobeNewswire
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
May 19, 2026

Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1

Indeterminate GlobeNewswire
Seven Peer-Reviewed Studies Expand Research Into Vielight’s Light-Based Neurotechnology
May 19, 2026

Seven Peer-Reviewed Studies Expand Research Into Vielight’s Light-Based Neurotechnology

Indeterminate GlobeNewswire
Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC
May 19, 2026

Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC

Indeterminate GlobeNewswire
BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
May 19, 2026

BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

Indeterminate GlobeNewswire
Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks
May 19, 2026

Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks

Indeterminate GlobeNewswire
Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development
May 19, 2026

Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development

Indeterminate GlobeNewswire
BrainHQ Awarded the Gold: Earns Trusted Digital Badge from APA Labs, a unit of American Psychological Association Services, Inc.
May 19, 2026

BrainHQ Awarded the Gold: Earns Trusted Digital Badge from APA Labs, a unit of American Psychological Association Services, Inc.

Indeterminate GlobeNewswire
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
May 19, 2026

Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform

Indeterminate GlobeNewswire
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split
May 19, 2026

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

Indeterminate GlobeNewswire
TRUE-See Reports New Peer-Reviewed Publication that Highlights the Critical Role of Accuracy and Quality Standards in Medical Photography
May 19, 2026

TRUE-See Reports New Peer-Reviewed Publication that Highlights the Critical Role of Accuracy and Quality Standards in Medical Photography

Indeterminate GlobeNewswire
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
May 19, 2026

SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Health Review Macao

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.